OMEROS CORP Lease Obligation Incurred
OMEROS CORP (OMER) reported Lease Obligation Incurred of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalLeaseObligationsIncurred · last filed 2026-03-31
- OMEROS CORP lease obligation incurred for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- OMEROS CORP lease obligation incurred for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- OMEROS CORP lease obligation incurred for the quarter ending 2024-12-31 was $1.01M, a 216.88% increase year-over-year.
- OMEROS CORP lease obligation incurred for the quarter ending 2024-09-30 was $140.00K, a 6.06% increase year-over-year.
- OMEROS CORP lease obligation incurred for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- OMEROS CORP lease obligation incurred for fiscal 2024 was $1.52M, a 59.98% increase from fiscal 2023.
- OMEROS CORP lease obligation incurred for fiscal 2023 was $952.00K, a 2280.00% increase from fiscal 2022.
- OMEROS CORP lease obligation incurred for fiscal 2022 was $40.00K, a 86.16% decline from fiscal 2021.
| Period end | Lease Obligation Incurred 3 month | Lease Obligation Incurred 6 month | Lease Obligation Incurred 6 month as first filed | Lease Obligation Incurred 9 month | Lease Obligation Incurred 12 month | Lease Obligation Incurred 204 month | Lease Obligation Incurred 207 month |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | |||||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | ||||||
| 2024-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.15M derived: sum of 2 quarters · filed 2026-03-31 | $1.52M 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | $140.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $509.00K 10-Q · filed 2025-11-13 | |||||
| 2024-06-30 | $369.00K 10-Q · filed 2025-08-14 | ||||||
| 2023-12-31 | $320.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $452.00K derived: sum of 2 quarters · filed 2026-03-31 | $952.00K 10-K · filed 2026-03-31 | ||||
| 2023-09-30 | $132.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $632.00K 10-Q · filed 2024-11-13 | |||||
| 2023-06-30 | $500.00K 10-Q · filed 2024-08-07 | ||||||
| 2022-12-31 | -$766.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$517.00K derived: sum of 2 quarters · filed 2025-03-31 | $40.00K 10-K · filed 2025-03-31 | ||||
| 2022-09-30 | $249.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $806.00K 10-Q · filed 2022-11-09 | |||||
| 2022-06-30 | $557.00K 10-Q · filed 2023-08-09 | ||||||
| 2021-12-31 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $250.00K derived: sum of 2 quarters · filed 2024-04-01 | $289.00K 10-K · filed 2024-04-01 | ||||
| 2021-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $139.00K 10-Q · filed 2022-11-09 | |||||
| 2021-06-30 | $39.00K 10-Q · filed 2022-08-09 | ||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $172.00K derived: sum of 2 quarters · filed 2023-03-13 | $194.00K derived: sum of 3 quarters · filed 2023-03-13 | $216.00K 10-K · filed 2023-03-13 | |||
| 2020-09-30 | $172.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $194.00K derived: sum of 2 quarters · filed 2021-11-09 | $216.00K 10-Q · filed 2021-11-09 | $770.00K derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | $22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $44.00K 10-Q · filed 2021-08-09 | $598.00K derived: sum of 3 quarters · filed 2022-03-01 | $598.00K derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | $22.00K 10-Q · filed 2021-05-10 | $576.00K derived: sum of 2 quarters · filed 2022-03-01 | $576.00K derived: sum of 3 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $554.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $554.00K derived: sum of 2 quarters · filed 2022-03-01 | $1.44M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $886.00K 10-Q · filed 2020-11-09 | |||||
| 2019-06-30 | $886.00K 10-Q · filed 2020-08-10 | ||||||
| 2018-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.76M derived: sum of 2 quarters · filed 2021-03-01 | $2.12M derived: sum of 3 quarters · filed 2021-03-01 | $2.12M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $221.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $579.00K derived: sum of 2 quarters · filed 2019-11-12 | $579.00K 10-Q · filed 2019-11-12 | $1.09M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-06-30 | $358.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $358.00K 10-Q · filed 2019-08-08 | $867.00K derived: sum of 3 quarters · filed 2020-03-02 | $1.34M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 | $509.00K derived: sum of 2 quarters · filed 2020-03-02 | $978.00K derived: sum of 3 quarters · filed 2020-03-02 | $1.07M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2017-12-31 | $509.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $978.00K derived: sum of 2 quarters · filed 2020-03-02 | $1.07M derived: sum of 3 quarters · filed 2020-03-02 | $1.14M 10-K · filed 2020-03-02 | |||
| 2017-09-30 | $469.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $562.00K derived: sum of 2 quarters · filed 2018-11-08 | $632.00K 10-Q · filed 2018-11-08 | $648.00K derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-06-30 | $93.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $163.00K 10-Q · filed 2018-08-09 | $0.00 10-Q · filed 2017-08-08 | $179.00K derived: sum of 3 quarters · filed 2019-03-01 | -$191.00K derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | $70.00K 10-Q · filed 2018-05-10 | $86.00K derived: sum of 2 quarters · filed 2019-03-01 | -$284.00K derived: sum of 3 quarters · filed 2019-03-01 | $474.00K derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2016-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$354.00K derived: sum of 2 quarters · filed 2019-03-01 | $404.00K derived: sum of 3 quarters · filed 2019-03-01 | $404.00K 10-K · filed 2019-03-01 | |||
| 2016-09-30 | -$370.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $388.00K derived: sum of 2 quarters · filed 2017-11-09 | $388.00K 10-Q · filed 2017-11-09 | $525.00K derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | $758.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $758.00K 10-Q · filed 2017-08-08 | $388.00K 10-Q · filed 2016-08-09 | $895.00K derived: sum of 3 quarters · filed 2018-03-01 | $895.00K derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-10 | $137.00K derived: sum of 2 quarters · filed 2018-03-01 | $137.00K derived: sum of 3 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | $137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $137.00K derived: sum of 2 quarters · filed 2018-03-01 | $137.00K 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $0.00 10-Q · filed 2016-11-09 | |||||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-09 | ||||||
| 2014-12-31 | $200.00K 10-K · filed 2017-03-16 | ||||||
| 2013-12-31 | $0.00 10-K · filed 2016-03-15 | ||||||
| 2012-12-31 | $30.00K 10-K · filed 2015-03-16 | ||||||
| 2011-12-31 | $0.00 10-K · filed 2014-03-13 | ||||||
| 2011-09-30 | $0.00 derived: 10-Q 207 month − 10-Q 204 month · filed 2011-11-08 | $201.00K 10-Q · filed 2011-11-08 | |||||
| 2011-06-30 | $201.00K 10-Q · filed 2011-08-09 | ||||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $201.00K 10-K · filed 2013-03-18 | |||||
| 2010-09-30 | $201.00K 10-Q · filed 2011-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |